Pune, India — 02/15/2018 — Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Segmentation: Global Intra-Uterine Contraceptive Devices Market
Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Get Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market
Table of Contents:
– RESEARCH METHODOLOGY
– MARKET OVERVIEW
– EXECUTIVE SUMMARY
– PREMIUM INSIGHTS
– GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
– GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
– GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET: COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT & APPROVALS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
– GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.2. DKT INTERNATIONAL
9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD
9.4. ALLERGEN, PLC
9.5. SMB CORPORATION
9.6. ACTAVIS PLC.
9.7 OCON MEDICAL LTD.
9.8 MONALISA NV
9.9 MEDISAFE DISTRIBUTION, INC.
9.10 MERIL LIFE SCIENCES PVT. LTD.
View Full Report Visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/
Market Drivers: Global Intra-Uterine Contraceptive Devices Market
Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD's.
Increased Rate of Unplanned Pregnancies:
Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent use, and use of methods with high typical use failure rates are reflected in the high rate of unintended adolescent pregnancies in the U.S.
Rising Number of Initiatives Undertaken By the Private Firms:
The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S. In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.
Favourable Insurance for IUCD's:
The insurance policy is propelling the IUCD market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S. are covered by insurance.
Growing Awareness of Contraceptive:
The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use. This is also one of the factors contributing to the growth of the market in Europe.
For More Details In-Depth Enquiry @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-intra-uterine-contraceptive-devices-market
Some of the major players operating in this market are:
Teva Pharmaceuticals Industries Ltd.
Mona Lisa N.V.
Melbea AG, Ocon Medical Ltd.
Pregna International Limited
Medical Engineering Corporation SA
SMB Corporation and Meril Life Sciences Pvt. Ltd.
Medu Scientific Ltd
China RH Contraceptives Co., Ltd
Sanghai Jolly Medical Education Co., Ltd
Bernstein Leibhard LLP
ZheijangDaji Medical Instruments, Ltd.
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Email: [email protected]
Investor: [email protected]
Visit Blog: http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
Latest posts by Jasmine Petters (see all)
- MediciNova to Present at the Cowen Health Care Conference in Boston - February 25, 2018
- Lucara Diamond Announces Acquistion of Clara Diamond Solutions Corporation - February 25, 2018
- Lucara Announces Board and Management Changes - February 25, 2018